Value added tax rate of tumor drugs dropped to 3%, 154 domestic drugs were impacted

Source: Ministry of Finance April 28, 2018 notice on value added tax policy for anticancer drugs (hereinafter referred to as the notice) was issued by the Ministry of Finance on April 27 ▍ from May 1, the value-added tax rate of tumor drugs will be reduced to 3% and the national financial authorities at all levels will be informed: from May 1, 2018, the general taxpayer of value-added tax will produce, sell, wholesale and retail anti-cancer drugs, and may choose to pay the value-added tax according to the simple method and the 3% collection rate The above-mentioned taxpayers shall choose a simple method to calculate and pay VAT, which shall not be changed within 36 months From May 1, 2018, the import value-added tax on anti-cancer drugs will be reduced by 3% Objective to encourage the development of anticancer pharmaceutical industry and reduce the cost of drug use for patients Taxpayers shall separately account for the sales of anti-cancer drugs In case of no separate accounting, the simple collection policy stipulated in Article 1 of this Circular shall not apply ▍ 103 preparations and 51 APIs the Ministry of Finance said that the anticancer drugs mentioned in the notice refer to the anticancer preparations and APIs approved and registered by the State Drug Administration, and the first batch of anticancer drugs list has been published The scope of anticancer drugs shall be adjusted dynamically, which shall be made clear by the Ministry of finance, the General Administration of customs, the State Administration of Taxation and the State Drug Administration according to the changes According to statistics, the first batch of anticancer drugs, including 103 preparations and 51 APIs, was released this time ▍ zero tariff and value-added tax reduction, which the State Council deployed 15 days ago, was set half a month ago On April 12, the premier of the State Council presided over the executive meeting of the State Council, and decided to reduce the import tariff of all general drugs, including anticancer drugs, alkaloid drugs with anticancer effect, etc to zero from May 1, and significantly reduce the added value tax burden in the production and import of anticancer drugs To achieve that, on April 23, the Ministry of Finance issued a document to cancel the import tariff of 28 drugs (see sabran's previous report: just now! 28 kinds of domestic drugs were impacted Attachment: anticancer drug preparation: anticancer drug substance